首页> 外文期刊>Journal of aerosol medicine and pulmonary drug delivery >Methacholine Challenge: Comparison of Airway Responsiveness Produced by a Vibrating Mesh Nebulizer Versus a Jet Nebulizer
【24h】

Methacholine Challenge: Comparison of Airway Responsiveness Produced by a Vibrating Mesh Nebulizer Versus a Jet Nebulizer

机译:甲咯素挑战:振动网雾化器与喷射雾化器产生的气道反应能力的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The latest methacholine challenge testing (MCT) guidelines published by the European Respiratory Society recommend the characterization of nebulizers before their use in clinics and research. Such investigations are necessary for accurately determining the provocative dose of methacholine causing a 20% fall in FEV_(1) (PD_(20)) delivered by a given device. The standard English Wright (Wright) jet nebulizer recommended in the 1999 guidelines by the American Thoracic Society has become difficult to obtain and possesses some characteristics that complicate the calculation of dose delivery from this device (e.g. evaporation). Our objective was to determine if the Aerogen~(?) Solo (Solo) vibrating mesh nebulizer provides similar methacholine challenge test results compared to the currently used Wright jet nebulizer. Methods: Sixty mild-to-moderate asthmatics were studied across three research sites in a randomized crossover study. Both methacholine challenges were completed at least 24 hours apart within a 2-week period. Testing with the Wright device was performed as per the 2-minute tidal breathing protocol. The Solo study arm followed the same procedure except for a shorter inhalation time of 1 minute. The provocative concentration of methacholine causing a 20% fall in FEV_(1) (PC_(20)) and the methacholine PD_(20) were calculated following each methacholine challenge. Results: The geometric mean methacholine PC_(20) values for the Solo and the Wright differed statistically (0.65 mg/mL vs. 2.58 mg/mL, respectively, p p = 0.018). Conclusions: The comparability of PD_(20) values between the Solo and the Wright validates the importance of reporting airway responsiveness to methacholine in terms of dose and not concentration, as stressed in the latest testing guidelines. This finding along with several benefits associated with the Solo make it a promising nebulizer for performing MCT.
机译:背景:欧洲呼吸协会公布的最新甲素挑战检测(MCT)指南建议在他们在诊所和研究中使用前表征雾化器。这种调查是准确地确定甲素的填充剂剂量,导致给定装置递送的FEV_(1)(PD_(20))下降20%。标准的英国赖特(Wright)喷气式雾化器推荐在1999年美国胸部社会的指导方针难以获得并具有一些特征,使来自该装置的剂量递送的计算复杂化(例如蒸发)。我们的目的是确定AEROGEN〜(α)SOLO(SOLO)振动网状雾化器是否提供了与目前使用的赖特喷射雾化器相比类似的甲素攻击试验结果。方法:在随机交叉研究中,在三个研究遗址中研究了六十次轻度至中度哮喘。在2周内至少24小时完成甲素挑战,均在2周内完成。使用2分钟的潮气呼吸协议进行使用赖特设备进行测试。独奏研究手臂遵循相同的程序,除了1分钟的更短的吸入时间。在每种甲素攻击后计算导致20%的甲素溶液含有20%的甲素(PC_(20))和甲素PD_(20)。结果:独奏和赖特的几何平均甲素PC_(20)值统计学(分别为0.65mg / ml与2.58mg / ml,P P = 0.018)。结论:PD_(20)单位与赖特之间的价值的可比性验证了在最新检测指南中强调的剂量和不集中的报告对甲素对甲素的回收性的重要性。这种发现以及与独奏相关的几个好处使其成为执行MCT的有希望的雾化器。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号